NACDS RxImpact Day comes at a critical time for industry
Hundreds of community pharmacy executives, pharmacy students and other pharmacy advocates representing 41,000 chain pharmacies took to Capitol Hill last week for the 5th Annual NACDS RxImpact Day and conducted more than 400 meetings with U.S. senators and representatives.
With implementation of the Patient Protection and Affordable Care Act in 2014, Congress desperately needs to hear from a stakeholder that can actually save the system money. There is growing awareness on the Hill that for every $1 invested in MTM, you save $10 to $12 — the bill introduced this week by Sens. Pat Roberts and Kay Hagan to expand MTM is a strong demonstration of that.
"NACDS appreciates the leadership of Sens. Hagan and Roberts in spearheading this commonsense legislation, as well as the support of original cosponsors Sens. Brown, Franken, Johnson and Klobuchar. This bill can help patients understand the importance of taking their medications as prescribed,” stated NACDS president and CEO Steve Anderson in a prepared statement. “Innovative pharmacy services such as MTM help to improve patient health and healthcare affordability, especially for those suffering from chronic conditions such as diabetes, hypertension, asthma and other conditions.”
It is likely that legislation will draw more supporters in the weeks ahead, as NACDS members held more than 400 deskside meetings with members of Congress from their home districts, and MTM was one of three key talking points all RxImpact attendees came prepared to hammer home.
To make sure lawmakers got the message, Drug Store News produced the third edition of its RxImpact supplement profiling what community pharmacy is doing to advance patient care, lower costs, improve outcomes, and expand accessibility to quality care. The supplement was part of all RxImpact kits prepared as leave-behinds for members of Congress. The supplement was also hand-delivered to all members of the House and Senate.
The RxImpact Day event continues to grow in popularity. Participation was up 29% in 2013, with 34 companies attending (70% of industry), 38 states represented and 21 pharmacy schools.